|
|
OTC Healthcare in Ireland to 2013
|
|||||||||||
| Preis** (Lieferformat): |
Versandkostenfrei ** WICHTIG: Alle Preise sind netto ausgewiesen. Abhängig von Versand- und Leistungsort ist hierauf noch USt. zu entrichten (Deutschland z.Z. 19%). Der korrekte Gesamtendpreis wird Ihnen mit der Angabe Ihrer Rechnungsadresse, USt-ID-Nr. etc. im Bestellverlauf ausgewiesen. Weitere Informationen zu den Bestandteilen des Kaufpreises finden Sie in unseren FAQs. |
Zahlen und Fakten zur Studie: | 192 Pages | |||||||||
| Inhalt der Studie: |
Introduction
This databook provides key data and information on the OTC healthcare market in Ireland. This report is a comprehensive resource for market, category and segment level data including val.....
Introduction This databook provides key data and information on the OTC healthcare market in Ireland. This report is a comprehensive resource for market, category and segment level data including value, distribution share and company & brand share. Scope *Contains information on:analgesics,medicated skin product,topical OTC,traditional,indigestion,cough&cold,plasters&Bandages,vitamins and first aid kits *Market,category and segment level information on value with historic (2003-2008) and forecast (2009-2013) data *Category level company and brand share as well as distribution share information for 2007 and 2008 *Review of the top two companies within the OTC healthcare market, including company overview, key facts and business description Highlights The market for OTC healthcare in Ireland increased at a compound annual growth rate of 5% between 2003 and 2008. The analgesics category led the OTC healthcare market in Ireland, accounting for a share of 20.2%. Leading players in Irish OTC healthcare market include Johnson & Johnson, GlaxoSmithKline Plc and Bayer AG. Reasons to Purchase *Develop business strategies by understanding the quantitative trends within the OTC healthcare market in Ireland *Design effective marketing and sales strategies by identifying key market categories and segments *Identify key players within the market to plan lucrative M&A, partnerships and agreements Report Highlights [Studien Infos ausblenden] |
|||||||||||
|
TABLE OF CONTENTS Chapter 1 Executive Summary 2 Summary market level: OTC healthcare 2 Summary category level: analgesics 3 Summary category level: topical OTC medicines 4 Summary category level: cough and cold preparations 5 Summary category level: indigestion preparations 6 Summary category level: medicated skin products 7 Summary category level: first aid kits 8 Summary category level: other OTC healthcare products 9 Summary category level: plasters & bandages 10 Summary category level: traditional medicines 11 Summary category level: vitamins and minerals 12 Chapter 2 Introduction 13 What is this report about? 13 How to use this report 13 Market definition 14 Chapter 3 Market Overview 30 Value analysis (Euro), 2003?08 30 Value analysis (Euro), 2008?13 32 Value analysis (US dollars), 2003?08 34 Value analysis (US dollars), 2008?13 35 Company and brand share analysis 37 Distribution analysis 44 Chapter 4 Leading Company Profiles 46 Johnson & Johnson 46 GlaxoSmithKline Plc 48 Chapter 5 Category Analysis: Analgesics 51 Value analysis (Euro), 2003?08 51 Value analysis (Euro), 2008?13 52 Value analysis (US dollars), 2003?08 54 Value analysis (US dollars), 2008?13 54 Company and brand share analysis 56 Distribution analysis 59 Chapter 6 Category Analysis: Topical OTC Medicines 61 Value analysis (Euro), 2003?08 61 Value analysis (Euro), 2008?13 62 Value analysis (US dollars), 2003?08 64 Value analysis (US dollars), 2008?13 65 Company and brand share analysis 67 Distribution analysis 70 Chapter 7 Category Analysis: Cough and Cold Preparations 72 Value analysis (Euro), 2003?08 72 Value analysis (Euro), 2008?13 73 Value analysis (US dollars), 2003?08 75 Value analysis (US dollars), 2008?13 76 Company and brand share analysis 78 Distribution analysis 82 Chapter 8 Category Analysis: Indigestion Preparations 84 Value analysis (Euro), 2003?08 84 Value analysis (Euro), 2008?13 85 Value analysis (US dollars), 2003?08 87 Value analysis (US dollars), 2008?13 87 Company and brand share analysis 89 Distribution analysis 91 Chapter 9 Category Analysis: Medicated Skin Products 93 Value analysis (Euro), 2003?08 93 Value analysis (Euro), 2008?13 94 Value analysis (US dollars), 2003?08 96 Value analysis (US dollars), 2008?13 97 Company and brand share analysis 99 Distribution analysis 102 Chapter 10 Category Analysis: First Aid Kits 104 Value analysis (Euro), 2003?08 104 Value analysis (Euro), 2008?13 105 Value analysis (US dollars), 2003?08 106 Value analysis (US dollars), 2008?13 106 Company and brand share analysis 107 Distribution analysis 110 Chapter 11 Category Analysis: Other OTC Healthcare Products 112 Value analysis (Euro), 2003?08 112 Value analysis (Euro), 2008?13 113 Value analysis (US dollars), 2003?08 115 Value analysis (US dollars), 2008?13 116 Company and brand share analysis 118 Distribution analysis 122 Chapter 12 Category Analysis: Plasters & Bandages 124 Value analysis (Euro), 2003?08 124 Value analysis (Euro), 2008?13 125 Value analysis (US dollars), 2003?08 127 Value analysis (US dollars), 2008?13 128 Company and brand share analysis 130 Distribution analysis 133 Chapter 13 Category Analysis: Traditional Medicines 135 Value analysis (Euro), 2003?08 135 Value analysis (Euro), 2008?13 136 Value analysis (US dollars), 2003?08 137 Value analysis (US dollars), 2008?13 137 Company and brand share analysis 138 Distribution analysis 141 Chapter 14 Category Analysis: Vitamins and Minerals 143 Value analysis (Euro), 2003?08 143 Value analysis (Euro), 2008?13 144 Value analysis (US dollars), 2003?08 146 Value analysis (US dollars), 2008?13 146 Company and brand share analysis 148 Distribution analysis 151 Chapter 15 Country Comparison 153 Value 153 Market share 157 Chapter 16 PESTLE Analysis 158 Summary 158 Political analysis 159 Economic analysis 162 Social analysis 165 Technology analysis 169 Legal analysis 173 Environmental analysis 176 Chapter 17 New Product Development 179 Product launches over time 179 Recent product launches 181 Chapter 18 Macroeconomic Profile 182 Macroeconomic indicators 182 Chapter 19 Research Methodology 187 Methodology overview 187 Secondary research 188 Market modeling 189 Creating an initial data model 189 Revising the initial data model 189 Creating a final estimate 190 Creating demographic value splits 190 Primary research 190 Data finalization 191 Ongoing research 191 Chapter 20 APPENDIX 192 Future readings 192 How to contact experts in your industry 192 Disclaimer 192 LIST OF FIGURES Figure 1: Ireland OTC healthcare value and value forecast, 2003?13 (€m, nominal prices) 33 Figure 2: Ireland OTC healthcare category growth comparison, by value, 2003?13 36 Figure 3: Ireland OTC healthcare company share, by value, 2007?08 (%) 41 Figure 4: Ireland OTC healthcare distribution channels, by value, 2007?08 (%) 45 Figure 5: Ireland analgesics value and value forecast, 2003?13 (€m, nominal prices) 53 Figure 6: Ireland analgesics category growth comparison, by value, 2003?13 55 Figure 7: Ireland analgesics company share, by value, 2007?08 (%) 57 Figure 8: Ireland analgesics distribution channels, by value, 2007?08 (%) 60 Figure 9: Ireland topical OTC medicines value and value forecast, 2003?13 (€m, nominal prices) 63 Figure 10: Ireland topical OTC medicines category growth comparison, by value, 2003?13 66 Figure 11: Ireland topical OTC medicines company share, by value, 2007?08 (%) 68 Figure 12: Ireland topical OTC medicines distribution channels, by value, 2007?08 (%) 71 Figure 13: Ireland cough and cold preparations value and value forecast, 2003?13 (€m, nominal prices) 74 Figure 14: Ireland cough and cold preparations category growth comparison, by value, 2003?13 77 Figure 15: Ireland cough and cold preparations company share, by value, 2007?08 (%) 80 Figure 16: Ireland cough and cold preparations distribution channels, by value, 2007?08 (%) 83 Figure 17: Ireland indigestion preparations value and value forecast, 2003?13 (€m, nominal prices) 86 Figure 18: Ireland indigestion preparations category growth comparison, by value, 2003?13 88 Figure 19: Ireland indigestion preparations distribution channels, by value, 2007?08 (%) 92 Figure 20: Ireland medicated skin products value and value forecast, 2003?13 (€m, nominal prices) 95 Figure 21: Ireland medicated skin products category growth comparison, by value, 2003?13 98 Figure 22: Ireland medicated skin products company share, by value, 2007?08 (%) 100 Figure 23: Ireland medicated skin products distribution channels, by value, 2007?08 (%) 103 Figure 24: Ireland first aid kits value and value forecast, 2003?13 (€m, nominal prices) 105 Figure 25: Ireland first aid kits company share, by value, 2007?08 (%) 108 Figure 26: Ireland first aid kits distribution channels, by value, 2007?08 (%) 111 Figure 27: Ireland other OTC healthcare products value and value forecast, 2003?13 (€m, nominal prices) 114 Figure 28: Ireland other OTC healthcare products category growth comparison, by value, 2003?13 117 Figure 29: Ireland other OTC healthcare products company share, by value, 2007?08 (%) 120 Figure 30: Ireland other OTC healthcare products distribution channels, by value, 2007?08 (%) 123 Figure 31: Ireland plasters & bandages value and value forecast, 2003?13 (€m, nominal prices) 126 Figure 32: Ireland plasters & bandages category growth comparison, by value, 2003?13 129 Figure 33: Ireland plasters & bandages company share, by value, 2007?08 (%) 131 Figure 34: Ireland plasters & bandages distribution channels, by value, 2007?08 (%) 134 Figure 35: Ireland traditional medicines value and value forecast, 2003?13 (€m, nominal prices) 136 Figure 36: Ireland traditional medicines company share, by value, 2007?08 (%) 139 Figure 37: Ireland traditional medicines distribution channels, by value, 2007?08 (%) 142 Figure 38: Ireland vitamins and minerals value and value forecast, 2003?13 (€m, nominal prices) 145 Figure 39: Ireland vitamins and minerals category growth comparison, by value, 2003?13 147 Figure 40: Ireland vitamins and minerals company share, by value, 2007?08 (%) 149 Figure 41: Ireland vitamins and minerals distribution channels, by value, 2007?08 (%) 152 Figure 42: Global OTC healthcare market split (value terms, 2008), top five countries 154 Figure 43: Global OTC healthcare market value, 2003–08, top five countries 156 Figure 44: Annual data review process 188 LIST OF TABLES Table 1: OTC healthcare category definitions 15 Table 2: OTC healthcare distribution channels 17 Table 3: Ireland OTC healthcare value, 2003?08 (€m, nominal prices) 31 Table 4: Ireland OTC healthcare value forecast, 2008?13 (€m, nominal prices) 32 Table 5: Ireland OTC healthcare value, 2003?08 ($m, nominal prices) 34 Table 6: Ireland OTC healthcare value forecast, 2008?13 ($m, nominal prices) 35 Table 7: Ireland OTC healthcare brand share, by value, 2007?08 (%) 37 Table 8: Ireland OTC healthcare value, by brand 2007?08 (€m, nominal prices) 39 Table 9: Ireland OTC healthcare company share by value, 2007?08 (%) 42 Table 10: Ireland OTC healthcare value, by company, 2007?08 (€m, nominal prices) 43 Table 11: Ireland OTC healthcare distribution channels, by value, 2007?08 (%) 44 Table 12: Ireland OTC healthcare value, by distribution channel, 2007?08 (€m, nominal prices) 44 Table 13: Johnson & Johnson key facts 46 Table 14: GlaxoSmithKline Plc key facts 48 Table 15: Ireland analgesics value, 2003?08 (€m, nominal prices) 51 Table 16: Ireland analgesics value forecast, 2008?13 (€m, nominal prices) 52 Table 17: Ireland analgesics value, 2003?08 ($m, nominal prices) 54 Table 18: Ireland analgesics value forecast, 2008?13 ($m, nominal prices) 54 Table 19: Ireland analgesics brand share, by value, 2007?08 (%) 56 Table 20: Ireland analgesics value, by brand 2007?08 (€m, nominal prices) 56 Table 21: Ireland analgesics company share by value, 2007?08 (%) 58 Table 22: Ireland analgesics value, by company, 2007?08 (€m, nominal prices) 58 Table 23: Ireland analgesics distribution channels, by value, 2007?08 (%) 59 Table 24: Ireland analgesics value, by distribution channel, 2007?08 (€m, nominal prices) 59 Table 25: Ireland topical OTC medicines value, 2003?08 (€m, nominal prices) 61 Table 26: Ireland topical OTC medicines value forecast, 2008?13 (€m, nominal prices) 62 Table 27: Ireland topical OTC medicines value, 2003?08 ($m, nominal prices) 64 Table 28: Ireland topical OTC medicines value forecast, 2008?13 ($m, nominal prices) 65 Table 29: Ireland topical OTC medicines brand share, by value, 2007?08 (%) 67 Table 30: Ireland topical OTC medicines value, by brand 2007?08 (€m, nominal prices) 67 Table 31: Ireland topical OTC medicines company share by value, 2007?08 (%) 69 Table 32: Ireland topical OTC medicines value, by company, 2007?08 (€m, nominal prices) 69 Table 33: Ireland topical OTC medicines distribution channels, by value, 2007?08 (%) 70 Table 34: Ireland topical OTC medicines value, by distribution channel, 2007?08 (€m, nominal prices) 70 Table 35: Ireland cough and cold preparations value, 2003?08 (€m, nominal prices) 72 Table 36: Ireland cough and cold preparations value forecast, 2008?13 (€m, nominal prices) 73 Table 37: Ireland cough and cold preparations value, 2003?08 ($m, nominal prices) 75 Table 38: Ireland cough and cold preparations value forecast, 2008?13 ($m, nominal prices) 76 Table 39: Ireland cough and cold preparations brand share, by value, 2007?08 (%) 78 Table 40: Ireland cough and cold preparations value, by brand 2007?08 (€m, nominal prices) 79 Table 41: Ireland cough and cold preparations company share by value, 2007?08 (%) 81 Table 42: Ireland cough and cold preparations value, by company, 2007?08 (€m, nominal prices) 81 Table 43: Ireland cough and cold preparations distribution channels, by value, 2007?08 (%) 82 Table 44: Ireland cough and cold preparations value, by distribution channel, 2007?08 (€m, nominal prices) 82 Table 45: Ireland indigestion preparations value, 2003?08 (€m, nominal prices) 84 Table 46: Ireland indigestion preparations value forecast, 2008?13 (€m, nominal prices) 85 Table 47: Ireland indigestion preparations value, 2003?08 ($m, nominal prices) 87 Table 48: Ireland indigestion preparations value forecast, 2008?13 ($m, nominal prices) 87 Table 49: Ireland indigestion preparations brand share, by value, 2007?08 (%) 89 Table 50: Ireland indigestion preparations value, by brand 2007?08 (€m, nominal prices) 89 Table 51: Ireland indigestion preparations company share by value, 2007?08 (%) 90 Table 52: Ireland indigestion preparations value, by company, 2007?08 (€m, nominal prices) 90 Table 53: Ireland indigestion preparations distribution channels, by value, 2007?08 (%) 91 Table 54: Ireland indigestion preparations value, by distribution channel, 2007?08 (€m, nominal prices) 91 Table 55: Ireland medicated skin products value, 2003?08 (€m, nominal prices) 93 Table 56: Ireland medicated skin products value forecast, 2008?13 (€m, nominal prices) 94 Table 57: Ireland medicated skin products value, 2003?08 ($m, nominal prices) 96 Table 58: Ireland medicated skin products value forecast, 2008?13 ($m, nominal prices) 97 Table 59: Ireland medicated skin products brand share, by value, 2007?08 (%) 99 Table 60: Ireland medicated skin products value, by brand 2007?08 (€m, nominal prices) 99 Table 61: Ireland medicated skin products company share by value, 2007?08 (%) 101 Table 62: Ireland medicated skin products value, by company, 2007?08 (€m, nominal prices) 101 Table 63: Ireland medicated skin products distribution channels, by value, 2007?08 (%) 102 Table 64: Ireland medicated skin products value, by distribution channel, 2007?08 (€m, nominal prices) 102 Table 65: Ireland first aid kits value, 2003?08 (€m, nominal prices) 104 Table 66: Ireland first aid kits value forecast, 2008?13 (€m, nominal prices) 105 Table 67: Ireland first aid kits value, 2003?08 ($m, nominal prices) 106 Table 68: Ireland first aid kits value forecast, 2008?13 ($m, nominal prices) 106 Table 69: Ireland first aid kits brand share, by value, 2007?08 (%) 107 Table 70: Ireland first aid kits value, by brand 2007?08 (€m, nominal prices) 107 Table 71: Ireland first aid kits company share by value, 2007?08 (%) 109 Table 72: Ireland first aid kits value, by company, 2007?08 (€m, nominal prices) 109 Table 73: Ireland first aid kits distribution channels, by value, 2007?08 (%) 110 Table 74: Ireland first aid kits value, by distribution channel, 2007?08 (€m, nominal prices) 110 Table 75: Ireland other OTC healthcare products value, 2003?08 (€m, nominal prices) 112 Table 76: Ireland other OTC healthcare products value forecast, 2008?13 (€m, nominal prices) 113 Table 77: Ireland other OTC healthcare products value, 2003?08 ($m, nominal prices) 115 Table 78: Ireland other OTC healthcare products value forecast, 2008?13 ($m, nominal prices) 116 Table 79: Ireland other OTC healthcare products brand share, by value, 2007?08 (%) 118 Table 80: Ireland other OTC healthcare products value, by brand 2007?08 (€m, nominal prices) 119 Table 81: Ireland other OTC healthcare products company share by value, 2007?08 (%) 121 Table 82: Ireland other OTC healthcare products value, by company, 2007?08 (€m, nominal prices) 121 Table 83: Ireland other OTC healthcare products distribution channels, by value, 2007?08 (%) 122 Table 84: Ireland other OTC healthcare products value, by distribution channel, 2007?08 (€m, nominal prices) 122 Table 85: Ireland plasters & bandages value, 2003?08 (€m, nominal prices) 124 Table 86: Ireland plasters & bandages value forecast, 2008?13 (€m, nominal prices) 125 Table 87: Ireland plasters & bandages value, 2003?08 ($m, nominal prices) 127 Table 88: Ireland plasters & bandages value forecast, 2008?13 ($m, nominal prices) 128 Table 89: Ireland plasters & bandages brand share, by value, 2007?08 (%) 130 Table 90: Ireland plasters & bandages value, by brand 2007?08 (€m, nominal prices) 130 Table 91: Ireland plasters & bandages company share by value, 2007?08 (%) 132 Table 92: Ireland plasters & bandages value, by company, 2007?08 (€m, nominal prices) 132 Table 93: Ireland plasters & bandages distribution channels, by value, 2007?08 (%) 133 Table 94: Ireland plasters & bandages value, by distribution channel, 2007?08 (€m, nominal prices) 133 Table 95: Ireland traditional medicines value, 2003?08 (€m, nominal prices) 135 Table 96: Ireland traditional medicines value forecast, 2008?13 (€m, nominal prices) 136 Table 97: Ireland traditional medicines value, 2003?08 ($m, nominal prices) 137 Table 98: Ireland traditional medicines value forecast, 2008?13 ($m, nominal prices) 137 Table 99: Ireland traditional medicines brand share, by value, 2007?08 (%) 138 Table 100: Ireland traditional medicines value, by brand 2007?08 (€m, nominal prices) 138 Table 101: Ireland traditional medicines company share by value, 2007?08 (%) 140 Table 102: Ireland traditional medicines value, by company, 2007?08 (€m, nominal prices) 140 Table 103: Ireland traditional medicines distribution channels, by value, 2007?08 (%) 141 Table 104: Ireland traditional medicines value, by distribution channel, 2007?08 (€m, nominal prices) 141 Table 105: Ireland vitamins and minerals value, 2003?08 (€m, nominal prices) 143 Table 106: Ireland vitamins and minerals value forecast, 2008?13 (€m, nominal prices) 144 Table 107: Ireland vitamins and minerals value, 2003?08 ($m, nominal prices) 146 Table 108: Ireland vitamins and minerals value forecast, 2008?13 ($m, nominal prices) 146 Table 109: Ireland vitamins and minerals brand share, by value, 2007?08 (%) 148 Table 110: Ireland vitamins and minerals value, by brand 2007?08 (€m, nominal prices) 148 Table 111: Ireland vitamins and minerals company share by value, 2007?08 (%) 150 Table 112: Ireland vitamins and minerals value, by company, 2007?08 (€m, nominal prices) 150 Table 113: Ireland vitamins and minerals distribution channels, by value, 2007?08 (%) 151 Table 114: Ireland vitamins and minerals value, by distribution channel, 2007?08 (€m, nominal prices) 151 Table 115: Global OTC healthcare market value, 2008 153 Table 116: Global OTC healthcare market split (value terms ($m), 2008), top five countries 156 Table 117: Leading players, top five countries 157 Table 118: Analysis of Ireland’s political landscape 159 Table 119: Analysis of the Irish economy 162 Table 120: Analysis of Ireland’s social system 165 Table 121: Analysis of Ireland’s technology landscape 169 Table 122: Analysis of Ireland’s legal landscape 173 Table 123: Analysis of Ireland’s environmental landscape 176 Table 124: Ireland OTC healthcare new product launches reports, by company (top five companies), 2008 179 Table 125: Ireland OTC healthcare new product launches SKUs, by company (top five companies), 2008 179 Table 126: Ireland OTC healthcare new product launches (reports), by flavor and fragrances, 2008 180 Table 127: Ireland OTC healthcare new product launches (reports), by ingredients (top 10 ingredients), 2008 180 Table 128: Ireland OTC healthcare new product launches (reports), by package tags or claims (top 10 claims), 2008 181 Table 129: Ireland OTC healthcare new product launches - recent five launches 2008 181 Table 130: Ireland population, by age group, 2003?08 (millions) 182 Table 131: Ireland population forecast, by age group, 2008?13 (millions) 183 Table 132: Ireland population, by gender, 2003?08 (millions) 183 Table 133: Ireland population forecast, by gender, 2008?13 (millions) 184 Table 134: Ireland nominal GDP, 2003?08 (€bn, nominal prices) 184 Table 135: Ireland nominal GDP forecast, 2008?13 (€bn, nominal prices) 184 Table 136: Ireland real GDP, 2003?08 (€bn, 2000 prices) 185 Table 137: Ireland real GDP forecast, 2008?13 (€bn, 2000 prices) 185 Table 138: Ireland real GDP, 2003?08 ($bn, 2000 prices) 185 Table 139: Ireland real GDP forecast, 2008?13 ($bn, 2000 prices) 186 Table 140: Ireland consumer price index, 2003?08 (2000=100) 186 Table 141: Ireland consumer price index, 2008?13 (2000=100) 186 [Inhaltsverzeichnis ausblenden] |
||||||||||||
| Hinweis: | * Der Rechnungsbetrag für diese Studie wird in $ (Dollar) ausgewiesen. Kunden aus dem Inland bekommen von uns eine Rechnung in Euro, umgerechnet zum letztwöchigen Schlusskurs | |||||||||||
|
|
||||||||||||


